Details for New Drug Application (NDA): 202771
✉ Email this page to a colleague
The generic ingredient in NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 202771
| Tradename: | NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL |
| Applicant: | Xiromed |
| Ingredient: | ethinyl estradiol; norethindrone acetate |
| Patents: | 0 |
Pharmacology for NDA: 202771
| Mechanism of Action | Estrogen Receptor Agonists |
Suppliers and Packaging for NDA: 202771
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 202771 | ANDA | Mylan Pharmaceuticals Inc. | 0378-7280 | 0378-7280-53 | 3 POUCH in 1 CARTON (0378-7280-53) / 1 BLISTER PACK in 1 POUCH (0378-7280-85) / 21 TABLET in 1 BLISTER PACK |
| NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-21 | 202771 | ANDA | Xiromed, LLC | 70700-313 | 70700-313-79 | 3 POUCH in 1 CARTON (70700-313-79) / 1 BLISTER PACK in 1 POUCH / 21 TABLET in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-21 | Strength | 0.02MG;1MG | ||||
| Approval Date: | Nov 6, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
